Retinopathy of Prematurity

Anti-VEGF treatment for ROP: which drug and what dose?

Research output: Contribution to journalEditorial

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)476-478
Number of pages3
JournalJournal of AAPOS
Volume20
Issue number6
DOIs
StatePublished - Dec 1 2016
Externally publishedYes

Fingerprint

Retinopathy of Prematurity
Vascular Endothelial Growth Factor A
Pharmaceutical Preparations
ROP

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Ophthalmology

Cite this

Retinopathy of Prematurity : Anti-VEGF treatment for ROP: which drug and what dose? / Wallace, David K.

In: Journal of AAPOS, Vol. 20, No. 6, 01.12.2016, p. 476-478.

Research output: Contribution to journalEditorial

@article{14a8b1a5007e4865ac0b7d770ba6f761,
title = "Retinopathy of Prematurity: Anti-VEGF treatment for ROP: which drug and what dose?",
author = "Wallace, {David K.}",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.jaapos.2016.08.013",
language = "English (US)",
volume = "20",
pages = "476--478",
journal = "Journal of AAPOS",
issn = "1091-8531",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Retinopathy of Prematurity

T2 - Anti-VEGF treatment for ROP: which drug and what dose?

AU - Wallace, David K.

PY - 2016/12/1

Y1 - 2016/12/1

UR - http://www.scopus.com/inward/record.url?scp=85001076394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85001076394&partnerID=8YFLogxK

U2 - 10.1016/j.jaapos.2016.08.013

DO - 10.1016/j.jaapos.2016.08.013

M3 - Editorial

VL - 20

SP - 476

EP - 478

JO - Journal of AAPOS

JF - Journal of AAPOS

SN - 1091-8531

IS - 6

ER -